MPO and chronic kidney disease: In group ORD, ORD plus, overall and overall plus, we found MPO -463G > A was associated with increased risk of CKD in allelic comparison (A vs. G), heterozygote comparison (GA vs. GG) and dominant model (GA + AA vs. GG), however, the results lacked stability.